Drug intelligence / Profile preview

Herba Asimor

Development stage
Phase 3
Lead developer
Dexa Medica
Modality
Peptides, Small Molecules
Administration
Oral
01

Overview

Herba Asimor is an Indonesian Modern Medicine (OMAI) developed by Dexa Medica Group's Dexa Laboratories of Biomolecular Sciences (DLBS) to address insufficient milk supply in postpartum lactating mothers. It is a combination product featuring Galatonol—a bioactive fraction derived from *Sauropus androgynus* (katuk) and *Coleus amboinicus* (torbangun) leaves—and Striatin, a bioactive fraction from *Channa striata* (snakehead fish). The product is manufactured using Advanced Fractionation Technology (AFT) to ensure high purity and biological activity. Mechanistically, Herba Asimor works by upregulating the expression of genes for prolactin and oxytocin, the key hormones involved in milk synthesis and the let-down reflex. Clinical studies and consumer reports indicate significant increases in breast milk volume within days of starting supplementation.

Brand names
Herba Asimor
Other names
Galatonol + StriatinOMAI Herba Asimor
02

Targets

Oxytocin receptorPRLR (Prolactin receptor)

Beyond the preview

Go deeper on Herba Asimor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herba Asimor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call